The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis

By Lee Eun-Ha  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 11-25

Springer Publishing Company

Access to resources Recommend Favorite

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

By Obdeijn Inge-Marie   Winter-Warnars Gonneke   Mann Ritse   Hooning Maartje   Hunink M.   Tilanus-Linthorst Madeleine  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 577-582

Springer Publishing Company

Access to resources Recommend Favorite

Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study

By Andritsch E.  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 10-18

Springer Publishing Company

Access to resources Recommend Favorite

The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation

By Jakubowska Anna   Gronwald Jacek   Górski Bohdan   Huzarski Tomasz   Byrski Tomasz   Benner Axel   Lubiński Jan   Scott Rodney J.   Hamann Ute  

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite